Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

434 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug Discovery of DKK1 Inhibitors.
Jiang H, Zhang Z, Yu Y, Chu HY, Yu S, Yao S, Zhang G, Zhang BT. Jiang H, et al. Among authors: chu hy. Front Pharmacol. 2022 Mar 9;13:847387. doi: 10.3389/fphar.2022.847387. eCollection 2022. Front Pharmacol. 2022. PMID: 35355709 Free PMC article. Review.
Dickkopf-1: A Promising Target for Cancer Immunotherapy.
Chu HY, Chen Z, Wang L, Zhang ZK, Tan X, Liu S, Zhang BT, Lu A, Yu Y, Zhang G. Chu HY, et al. Front Immunol. 2021 May 20;12:658097. doi: 10.3389/fimmu.2021.658097. eCollection 2021. Front Immunol. 2021. PMID: 34093545 Free PMC article. Review.
Cathepsin K: The Action in and Beyond Bone.
Dai R, Wu Z, Chu HY, Lu J, Lyu A, Liu J, Zhang G. Dai R, et al. Among authors: chu hy. Front Cell Dev Biol. 2020 Jun 4;8:433. doi: 10.3389/fcell.2020.00433. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32582709 Free PMC article. Review.
Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice.
Wang L, Yu Y, Ni S, Li D, Liu J, Xie D, Chu HY, Ren Q, Zhong C, Zhang N, Li N, Sun M, Zhang ZK, Zhuo Z, Zhang H, Zhang S, Li M, Xia W, Zhang Z, Chen L, Shang P, Pan X, Lu A, Zhang BT, Zhang G. Wang L, et al. Among authors: chu hy. Theranostics. 2022 Jul 18;12(13):5645-5674. doi: 10.7150/thno.63177. eCollection 2022. Theranostics. 2022. PMID: 35966595 Free PMC article.
Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses.
Ruiz F, Foreman W, Lilly M, Baharani VA, Depierreux DM, Chohan V, Taylor AL, Guenthoer J, Ralph D, Matsen FA, Chu HY, Bieniasz PD, Côté M, Starr TN, Overbaugh J. Ruiz F, et al. Among authors: chu hy. bioRxiv [Preprint]. 2024 Apr 25:2024.04.24.590836. doi: 10.1101/2024.04.24.590836. bioRxiv. 2024. PMID: 38712126 Free PMC article. Preprint.
434 results